World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
28035
World Ranking
14550
National Ranking
7363

Overview

Andrew D. Krystal is affiliated with the University of California, San Francisco in the United States. Their work spans multiple disciplines with a primary focus on neuroscience, medicine, and psychology, demonstrated by a significant number of publications in these fields. Their research encompasses subfields such as cognitive neuroscience, experimental and cognitive psychology, neurology, endocrine and autonomic systems, and clinical psychology.

Their recent publications include the following notable papers:

  • Closed-loop neuromodulation in an individual with treatment-resistant depression, 2021, Nature Medicine
  • International Consensus Statement on Obstructive Sleep Apnea, 2022, International Forum of Allergy & Rhinology
  • State-dependent responses to intracranial brain stimulation in a patient with depression, 2021, Nature Medicine
  • A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia, 2020, Nature Medicine
  • A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials, 2021, Molecular Psychiatry

The scientist regularly collaborates with several frequent coauthors, including:

  • Edward F. Chang
  • Leo P. Sugrue
  • Kristin K. Sellers
  • Joline M. Fan
  • Ankit N. Khambhati

Their work has been published frequently in the following venues:

  • SLEEP
  • Brain Stimulation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • JAMA Psychiatry
  • Biological Psychiatry

Research topics addressed by Andrew D. Krystal include:

  • Sleep and related disorders
  • Sleep and Wakefulness Research
  • Functional Brain Connectivity Studies
  • Neurological disorders and treatments
  • Circadian rhythm and melatonin
  • Transcranial Magnetic Stimulation Studies
  • Treatment of Major Depression

Best Publications

  • The Consensus Sleep Diary: Standardizing Prospective Sleep Self-Monitoring

    Colleen E. Carney;Daniel J. Buysse;Sonia Ancoli-Israel;Jack D. Edinger

  • National Sleep Foundation's sleep quality recommendations: first report.

    Maurice Ohayon;Emerson M. Wickwire;Max Hirshkowitz;Max Hirshkowitz;Steven M. Albert

  • Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline

    Michael J. Sateia;Daniel J. Buysse;Andrew D. Krystal;David N. Neubauer

  • British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

    S. J. Wilson;D. J. Nutt;C. Alford;S. V. Argyropoulos

  • Measuring sleep quality.

    Andrew D. Krystal;Jack D. Edinger;Jack D. Edinger

  • Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression

    Shawn M. McClintock;Shawn M. McClintock;Irving M. Reti;Linda L. Carpenter;William M. McDonald

  • Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

    Andrew D. Krystal;James K. Walsh;Eugene Laska;Judy Caron

  • Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.

    Maurizio Fava;W. Vaughn McCall;Andrew Krystal;Thomas Wessel

  • Closed-loop neuromodulation in an individual with treatment-resistant depression.

    Katherine W. Scangos;Katherine W. Scangos;Ankit N. Khambhati;Ankit N. Khambhati;Patrick M. Daly;Patrick M. Daly;Ghassan S. Makhoul;Ghassan S. Makhoul

  • Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: Clinical predictors of outcome in a multisite, randomized controlled clinical trial

    Sarah H. Lisanby;Mustafa M. Husain;Peter B. Rosenquist;Daniel Maixner

  • NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes.

    Andrew D. Krystal;Jack D. Edinger;William K. Wohlgemuth;Gail R. Marsh

  • PSYCHIATRIC DISORDERS AND SLEEP

    Andrew D. Krystal

  • Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial.

    Jack D. Edinger;William K. Wohlgemuth;Andrew D. Krystal;John R. Rice

  • Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

    David Michelson;Ellen Snyder;Erin Paradis;Mary Chengan-Liu

  • Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy

    Philip M. Becker;Andrew O. Jamieson;Carolyn E. Jewel;Richard K. Bogan

  • Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

    W. Joseph Herring;Kathryn M. Connor;Neely Ivgy-May;Ellen Snyder

  • A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.

    Colleen E. Carney;Zindel V. Segal;Jack D. Edinger;Andrew D. Krystal

  • An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia

    Thomas Roth;James K. Walsh;Andrew Krystal;Thomas Wessel

  • Nightly Treatment of Primary Insomnia With Eszopiclone for Six Months: Effect on Sleep, Quality of Life, and Work Limitations

    James K. Walsh;Andrew D. Krystal;David A. Amato;Robert Rubens

  • Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study

    Andrew D. Krystal;Milton Erman;Gary K. Zammit;C. Soubrane

Frequent Co-Authors

Jack D. Edinger
Jack D. Edinger Duke University
Thomas Roth
Thomas Roth Wayne State University
Ruth M. Benca
Ruth M. Benca University of California, Irvine
Daniel J. Buysse
Daniel J. Buysse University of Pittsburgh
Sarah H. Lisanby
Sarah H. Lisanby Arizona State University
Rachel Manber
Rachel Manber Stanford University
Michael E. Thase
Michael E. Thase University of Pennsylvania
Edward F. Chang
Edward F. Chang University of California, San Francisco
Maurice M. Ohayon
Maurice M. Ohayon Stanford University
John H. Krystal
John H. Krystal Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring routes to a medical career in the USA, there are several online degree options to consider. Flexible study formats can help both newcomers and current healthcare workers advance quickly, often while continuing to work.

Many registered nurses seek advancement through rn bsn online programs no clinicals. These programs allow nurses to earn a Bachelor of Science in Nursing without commuting to campus or completing in-person clinicals, making them ideal for working professionals.

For those aiming for leadership in nursing, there are now options like the shortest online dnp program or easiest dnp programs. These Doctor of Nursing Practice pathways allow RNs and APRNs to earn top-tier credentials with a manageable time commitment and greater flexibility compared to traditional on-campus programs.

Looking for a fast way to start your healthcare journey? Accelerated options such as the 6 month lpn program online can get you working sooner. These condensed programs minimize classroom time, making a nursing career more accessible and affordable, yet still respected in the field.

Best Scientists Citing Andrew D. Krystal

Trending Scientists

Recently Published Articles